Findings Associated with Recurrence of Bacterial Vaginosis among Adolescents Attending Sexually Transmitted Diseases Clinics

Journal of Pediatric and Adolescent Gynecology

Volumn 20, Issue 4, 2007, Pages 225-231

  Brotman, Rebecca M ^a,b   Erbelding, Emily J ^c,d   Jamshidi, Roxanne M ^c   Klebanoff, Mark A ^b   Zenilman, Jonathan M ^c   Ghanem, Khalil G ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BALTIMORE CITY HEALTH DEPARTMENT   (United States)

Author keywords

Adolescent sexually transmitted disease; Bacterial vaginosis; Pelvic inflammatory disease; Recurrent

Indexed keywords

METRONIDAZOLE;

ADOLESCENT; ARTICLE; CONTRACEPTION; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; ORAL SEXUAL CONTACT; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; TRICHOMONAS VAGINALIS; VAGINITIS;

ADOLESCENT; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; VAGINOSIS, BACTERIAL;

EID: 34547174747     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2006.11.009     Document Type: Article

References (58)

1. Klebanoff S.J., Hillier S.L., Eschenbach D.A., et al. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 164 (1991) 94
2. Pybus V., and Onderdonk A.B. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis 175 (1997) 406
3. Martin H.L., Richardson B.A., Nyange P.M., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180 (1999) 1863
4. Wiesenfeld H.C., Hillier S.L., Krohn M.A., et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 36 (2003) 663
5. Cherpes T.L., Meyn L.A., Krohn M.A., et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 37 (2003) 319
6. Cohen C.R., Duerr A., Pruithithada N., et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9 (1995) 1093
7. Taha T.E., Hoover D.R., Dallabetta G.A., et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12 (1998) 1699
8. Cu-Uvin S., Hogan J.W., Caliendo A.M., et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 33 (2001) 894
9. Ness R.B., Kip K.E., Hillier S.L., et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 162 (2005) 585
10. Westrom L., Joesoef R., Reynolds G., et al. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 19 (1992) 185
11. Koumans E.H., Markowitz L.E., Berman S.M., et al. A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis. Int J Gynaecol Obstet 67 Suppl. 1 (1999) S29
12. Ness R.B., Hillier S., Richter H.E., et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis?. J Natl Med Assoc 95 (2003) 201
13. Beigi R.H., Wiesenfeld H.C., Hillier S.L., et al. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis 191 (2005) 924
14. Schmid G.P. The epidemiology of bacterial vaginosis. Int J Gynaecol Obstet 67 Suppl. 1 (1999) S17
15. Marrazzo J.M., Koutsky L.A., Eschenbach D.A., et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 185 (2002) 1307
16. Schwebke J.R., Richey C.M., and Weiss H.L. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 180 (1999) 1632
17. Tchamouroff S.E., and Panja S.K. The association between receptive cunnilingus and bacterial vaginosis. Sex Transm Infect 76 (2000) 144
18. Hampton T. High prevalence of lesser-known STDs. JAMA 295 (2006) 2467
19. Shafer M.A., and Sweet R.L. Pelvic inflammatory disease in adolescent females. Epidemiology, pathogenesis, diagnosis, treatment, and sequelae. Pediatr Clin North Am 36 (1989) 513
20. Bump R.C., and Buesching III W.J. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol 158 (1988) 935
21. Brabin L., Roberts S.A., Fairbrother E., et al. Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics. Sex Transm Infect 81 (2005) 483
22. Tabrizi S.N., Fairley C.K., Bradshaw C.S., et al. Prevalence of Gardnerella vaginalis and Atopobium vaginae in virginal women. Sex Transm Dis 33 (2006) 663
23. Ferris M.J., Masztal A., and Martin D.H. Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol 42 (2004) 5892
24. Ferris M.J., Masztal A., Aldridge K.E., et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4 (2004) 5
25. Rodriguez J.M., Collins M.D., Sjoden B., et al. Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol 49 Pt 4 (1999) 1573
26. Burton J.P., Devillard E., Cadieux P.A., et al. Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation. J Clin Microbiol 42 (2004) 1829
27. Verhelst R., Verstraelen H., Claeys G., et al. Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 4 (2004) 16
28. Zhou X., Bent S.J., Schneider M.G., et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150 (2004) 2565
29. Sobel J.D. Vaginitis. N Engl J Med 337 (1997) 1896
30. Larsson P.G. Treatment of bacterial vaginosis. Int J STD AIDS 3 (1992) 239
31. Sobel J.D., Schmitt C., and Meriwether C. Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J Infect Dis 167 (1993) 783
32. Ivey J.B. The adolescent with pelvic inflammatory disease: assessment and management. Nurse Pract 22 (1997) 78
33. Aral S.O., Mosher W.D., and Cates Jr. W. Self-reported pelvic inflammatory disease in the United States, 1988. JAMA 266 (1991) 2570
34. Amsel R., Totten P.A., Spiegel C.A., et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14
35. Workowski K.A., and Berman S.M. CDC sexually transmitted diseases treatment guidelines. Clin Infect Dis 35 (2002) S135
36. Sobel J.D. What's new in bacterial vaginosis and trichomoniasis?. Infect Dis Clin North Am 19 (2005) 387
37. Yen S., Shafer M.A., Moncada J., et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 102 (2003) 927
38. Baeten J.M., Nyange P.M., Richardson B.A., et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185 (2001) 380
39. Shoubnikova M., Hellberg D., Nilsson S., et al. Contraceptive use in women with bacterial vaginosis. Contraception 55 (1997) 355
40. Roy S. Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 165 (1991) 1240
41. Calzolari E., Masciangelo R., Milite V., et al. Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70 (2000) 341
42. Korn A.P., Bolan G., Padian N., et al. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 85 (1995) 387
43. Ness R.B., Hillier S.L., Kip K.E., et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 104 (2004) 761
44. Sweet R.L., Mills J., Hadley K.W., et al. Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol 134 (1979) 68
45. Bradshaw C.S., Morton A.N., Garland S.M., et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 106 (2005) 105
46. Ghanem K.G., Hutton H.E., Zenilman J.M., et al. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm Infect 81 (2005) 421
47. Hawes S.E., Hillier S.L., Benedetti J., et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 174 (1996) 1058
48. Holzman C., Leventhal J.M., Qiu H., et al. Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health 91 (2001) 1664
49. Onderdonk A.B., Delaney M.L., Hinkson P.L., et al. Quantitative and qualitative effects of douche preparations on vaginal microflora. Obstet Gynecol 80 (1992) 333
50. Ness R.B., Hillier S.L., Richter H.E., et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100 (2002) 765
51. Brotman R, Erbelding E, Colletta L, et al: Vaginal Douching: A Survey of Normative Beliefs in a STD Clinic Population. Presented at The International Society for Sexually Transmitted Disease Research, 15th Bi-Annual Congress, July 26-31, 2003, Ottawa, Canada
52. Ness R.B., Randall H., Richter H.E., et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health 94 (2004) 1327
53. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 80 (2004) 8
54. Wilson J.D., Shann S.M., Brady S.K., et al. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment. Int J STD AIDS 16 (2005) 736
55. Andersch B., Lindell D., Dahlen I., et al. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest 30 (1990) 114
56. Baylson F.A., Nyirjesy P., and Weitz M.V. Treatment of recurrent bacterial vaginosis with tinidazole. Obstet Gynecol 104 (2004) 931
57. Milani M., Barcellona E., and Agnello A. Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynecol Reprod Biol 109 (2003) 67
58. Sobel J.D., Ferris D., Schwebke J., et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 194 (2006) 1283-1289